Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety

A Shaito, DTB Thuan, HT Phu, THD Nguyen… - Frontiers in …, 2020 - frontiersin.org
Cardiovascular diseases (CVDs) are a significant health burden with an ever-increasing
prevalence. They remain the leading causes of morbidity and mortality worldwide. The use …

The role of interleukin-1 in general pathology

N Kaneko, M Kurata, T Yamamoto, S Morikawa… - Inflammation and …, 2019 - Springer
Abstract Interleukin-1, an inflammatory cytokine, is considered to have diverse physiological
functions and pathological significances and play an important role in health and disease. In …

MDSC; the most important cell you have never heard of

RJ Tesi - Trends in pharmacological sciences, 2019 - cell.com
The myeloid-derived suppressor cell (MDSC) is the 'queen bee'of the tumor
microenvironment. MDSCs protect the cancer from the patient's immune system, make the …

Empagliflozin protects heart from inflammation and energy depletion via AMPK activation

CN Koyani, I Plastira, H Sourij, S Hallström… - Pharmacological …, 2020 - Elsevier
Aims Sodium-glucose co-transporter 2 (SGLT2) were originally developed as kidney-
targeting anti-diabetic drugs. However, due to their beneficial cardiac off-target effects (as …

Cardiovascular comorbidities, inflammation, and cerebral small vessel disease

LE Evans, JL Taylor, CJ Smith… - Cardiovascular …, 2021 - academic.oup.com
Cerebral small vessel disease (cSVD) is the most common cause of vascular cognitive
impairment and affects all levels of the brain's vasculature. Features include diverse …

Aging, inflammation and cancer

B Bottazzi, E Riboli, A Mantovani - Seminars in immunology, 2018 - Elsevier
Aging is a key aspect of neoplasia at the level of cells, individuals and populations.
Unrestrained expression and production of inflammatory mediators is a key feature of aging …

Anti-inflammatory therapy for atherosclerosis: focusing on cytokines

AV Poznyak, D Bharadwaj, G Prasad… - International journal of …, 2021 - mdpi.com
Atherosclerosis is a well-known global health problem. Despite the high prevalence of the
disease, numerous aspects of pathogenesis remain unclear. Subsequently, there are still no …

The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction

T Hennessy, L Soh, M Bowman, R Kurup, C Schultz… - American heart …, 2019 - Elsevier
Background Following an acute myocardial infarction (MI), patients with persistently
elevated biomarkers of inflammation, in particular C-reactive protein (CRP), are at …

Reverse cardio‐oncology: cancer development in patients with cardiovascular disease

JP Aboumsallem, J Moslehi… - Journal of the American …, 2020 - Am Heart Assoc
Overwhelming epidemiological evidence demonstrate that cardiovascular disease and
cancer represent major health burdens in the United States, and they are the leading causes …

Role of inflammatory cell subtypes in heart failure

D Strassheim, EC Dempsey… - Journal of …, 2019 - Wiley Online Library
Inflammation is a well‐known feature of heart failure. Studies have shown that while some
inflammation is required for repair during injury and is protective, prolonged inflammation …